Company · CIK 1609351
Spark Therapeutics, Inc.
Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26
| CIK | 1609351 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | PA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-03-25 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-211993 | 2016-06-13 | 2017-08-03 | 3 | |
| 333-211841 | 2016-06-03 | 2016-06-22 | 2 | |
| 333-208227 | 2015-11-25 | 2015-12-16 | 4 | |
| 333-201318 | 2014-12-30 | 2015-01-30 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2017-08-03 | 424B5Shelf takedown | 333-211993 | 0001193125-17-246668 |
| 2016-06-22 | EFFECTDeclared effective | 333-211841 | 9999999995-16-004976 |
| 2016-06-14 | 424B5Shelf takedown | 333-211993 | 0001193125-16-620403 |
| 2016-06-13 | S-3ASRShelf registered | 333-211993 | 0001193125-16-620146 |
| 2016-06-03 | S-3Shelf registered | 333-211841 | 0001193125-16-612757 |
| 2015-12-16 | 424B1Final prospectus | 333-208227 | 0001193125-15-404834 |
| 2015-12-15 | EFFECTDeclared effective | 333-208227 | 9999999995-15-003293 |
| 2015-12-14 | S-1/AAmendment | 333-208227 | 0001193125-15-402568 |
| 2015-11-25 | S-1Registration filed | 333-208227 | 0001193125-15-388870 |
| 2015-01-30 | 424B4Final prospectus | 333-201318 | 0001193125-15-026535 |
| 2015-01-29 | EFFECTDeclared effective | 333-201318 | 9999999995-15-000250 |
| 2015-01-28 | S-1/AAmendment | 333-201318 | 0001193125-15-022513 |
| 2015-01-20 | S-1/AAmendment | 333-201318 | 0001193125-15-013888 |
| 2014-12-30 | S-1Registration filed | 333-201318 | 0001193125-14-457223 |
| 2014-09-24 | DRSDraft made public | 377-00789 | 0000950123-14-009803 |